Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor

被引:286
作者
Ehrt, S
Guo, XZV
Hickey, CM
Ryou, M
Monteleone, M
Riley, LW
Schnappinger, D
机构
[1] Cornell Univ, WMC, Dept Microbiol & Immunol, New York, NY 10021 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA
[3] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA
[4] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Mol Biol, New York, NY 10021 USA
关键词
D O I
10.1093/nar/gni013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene expression systems that allow the regulation of bacterial genes during an infection are valuable molecular tools but are lacking for mycobacterial pathogens. We report the development of mycobacterial gene regulation systems that allow controlling gene expression in fast and slow-growing mycobacteria, including Mycobacterium tuberculosis, using anhydrotetracycline (ATc) as inducer. The systems are based on the Escherichia coli Tn10-derived tet regulatory system and consist of a strong tet operator (tetO)-containing mycobacterial promoter, expression cassettes for the repressor TetR and the chemical inducer ATc. These systems allow gene regulation over two orders of magnitude in Mycobacterium smegmatis and M.tuberculosis. TetR-controlled gene expression was inducer concentration-dependent and maximal with ATc concentrations at least 10- and 20-fold below the minimal inhibitory concentration for M.smegmatis and M.tuberculosis, respectively. Using the essential mycobacterial gene ftsZ, we showed that these expression systems can be used to construct conditional knockouts and to analyze the function of essential mycobacterial genes. Finally, we demonstrated that these systems allow gene regulation in M.tuberculosis within the macrophage phagosome.
引用
收藏
页数:11
相关论文
共 54 条
[1]  
Aínsa JA, 1998, J BACTERIOL, V180, P5836
[2]   The challenges of tuberculosis on antimicrobial resistance [J].
REVISTA DE SAUDE PUBLICA, 2011, 45 (05) :997-1000
[3]   Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus [J].
Bastos, RG ;
Dellagostin, OA ;
Barletta, RG ;
Doster, AR ;
Nelson, E ;
Osorio, FA .
VACCINE, 2002, 21 (1-2) :21-29
[4]   Gene regulation by tetracyclines - Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes [J].
Berens, C ;
Hillen, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (15) :3109-3121
[5]  
BERENS C, 1992, J BIOL CHEM, V267, P1945
[6]   Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice [J].
Biet, F ;
Kremer, L ;
Wolowczuk, I ;
Delacre, M ;
Locht, C .
INFECTION AND IMMUNITY, 2002, 70 (12) :6549-6557
[7]   Improved green fluorescent protein by molecular evolution using DNA shuffling [J].
Crameri, A ;
Whitehorn, EA ;
Tate, E ;
Stemmer, WPC .
NATURE BIOTECHNOLOGY, 1996, 14 (03) :315-319
[8]   Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice [J].
da Cruz, FW ;
McBride, AJA ;
Conceiçao, FR ;
Dale, JW ;
McFadden, J ;
Dellagostin, OA .
VACCINE, 2001, 20 (5-6) :731-736
[9]   Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis [J].
De Rossi, E ;
Blokpoel, MCJ ;
Cantoni, R ;
Branzoni, M ;
Riccardi, G ;
Young, DB ;
De Smet, KAL ;
Ciferri, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1931-1937
[10]   An array of target-specific screening strains for antibacterial discovery [J].
DeVito, JA ;
Mills, JA ;
Liu, VG ;
Agarwal, A ;
Sizemore, CF ;
Yao, ZJ ;
Stoughton, DM ;
Cappiello, MG ;
Barbosa, MDFS ;
Foster, LA ;
Pompliano, DL .
NATURE BIOTECHNOLOGY, 2002, 20 (05) :478-483